ALKS Alkermes plc Forecast, Technical & Fundamental Analysis
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more
ALKS is expected to report earnings to fall ∞% to -3 cents per share on October 28
Q3'26
Est.
$-0.04
Q2'26
Beat
by $0.02
Q1'26
Beat
by $0.14
Q4'25
Missed
by $0.12
Q3'25
Beat
by $0.11
The last earnings report on July 28 showed earnings per share of 0 cents, beating the estimate of -1 cents. With 603.24K shares outstanding, the current market capitalization sits at 7.73B.
A.I.dvisor tells us that ALKS and VTRS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALKS and VTRS's prices will move in lockstep.
ALKS's Stochastic Oscillator is sitting in oversold zone for 4 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALKS advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .
ALKS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on August 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALKS as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
ALKS moved below its 50-day moving average on August 20, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ALKS crossed bearishly below the 50-day moving average on August 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALKS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for ALKS entered a downward trend on September 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALKS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.277) is normal, around the industry mean (47.010). P/E Ratio (121.329) is within average values for comparable stocks, (93.888). ALKS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.974). ALKS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.028). P/S Ratio (4.638) is also within normal values, averaging (177.089).
